Saturday, November 23, 2024 11/23/2024

Testing a System-level Implementation Intervention to Improve the Quality of Family-Based Services for Adolescent Substance Use

Award Number: R34DA044740
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Abstract This R34 study will first develop treatment quality assurance procedures designed to increase the adoption and quality of empirically supported family-based services (FBS) for adolescent substance use (ASU) in usual care, and then test two system-level implementation strategies for installing the new quality procedures in ASU treatment sites. FBS have achieved the strongest evidence base for treating ASU and are a prime candidate for upgrading the quality of ASU services in various systems of care. FBS comprise both family participation in services, the systemic parameters wherein family members are included in assessment and treatment activities; and family therapy techniques, the specific interventions that clinicians use to directly target family members and family functioning for change. For FBS to fulfill their potential to enhance ASU treatment systems, FBS implementation must be supported by effective quality assurance (QA) procedures designed to ensure that FBS are delivered with fidelity. To advance this effort, the proposed study will leverage a strong research-government partnership between the applicant organization and the New York single-state agency for SU services. The study will first develop innovative QA procedures (Aim 1) that use existing FBS quality metrics to promote high-fidelity FBS: Measurement Feedback System for Implementation (MFS-I), a pragmatic evidence-based method for increasing FBS quality by providing monthly feedback on therapist-reported FBS delivery along with brief online FBS training modules. The study will then experimentally compare two system- level implementation strategies designed to foster MFS-I utilization in usual care for ASU. Core Training Only will contain two 3-hour training sessions: Mapping existing FBS and identifying site goals for FBS improvement; and Installing and sustaining the MFS-I. Core + Facilitation is an additive strategy that will begin with the Core Training sessions and then continue with monthly facilitation meetings for one year to promote MFS-I use and progress toward FBS improvement. The study will feature a three-group cluster randomized trial testing Core Training Only versus Core + Facilitation versus no-intervention Control in 15 representative ASU clinics across New York State. MFS-I utilization data will be collected from Core Training and Core + Facilitation sites for one-year follow-up (after initial Core Training); FBS quality data on family participation and family therapy technique use will be collected from all sites over one-year follow-up; and client outcome data for all sites will be retrieved from administrative data warehouses over one-year baseline and one-year follow-up. These data will enable between-condition comparisons of FBS delivery (Aim 2: MFS-I utilization, family participation, family therapy technique use) and client outcomes (Aim 3: therapeutic goal achievement, substance use change). If study aims are achieved, investigators would be positioned to mount a fully powered RCT to test the effectiveness of these FBS quality improvement procedures at scale.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2022 ( Subtotal = -$22,488 )
2022	2021	PARTNERSHIP TO END ADDICTION	711 3RD AVE FL 5	NEW YORK	NY	10017	NEW YORK	USA	Drug Use and Addiction Research Programs	001	3	5/9/2022	SUPPLEMENT FOR EXPANSION	-$12,516
2022	2019	PARTNERSHIP TO END ADDICTION	711 3RD AVE FL 5	NEW YORK	NY	10017	NEW YORK	USA	Drug Use and Addiction Research Programs	000	3	5/9/2022	NON-COMPETING CONTINUATION	-$9,972
														Subtotal = -$22,488

Issue Date FY: 2021 ( Subtotal = $12,516 )
2021	2021	PARTNERSHIP TO END ADDICTION	485 LEXINGTON AVE STE 300	NEW YORK	NY	10017	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	3	5/27/2021	SUPPLEMENT FOR EXPANSION	$0
2021	2021	PARTNERSHIP TO END ADDICTION	485 LEXINGTON AVE STE 300	NEW YORK	NY	10017	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	3	5/25/2021	SUPPLEMENT FOR EXPANSION	$12,516
														Subtotal = $12,516

Issue Date FY: 2020 ( Subtotal = $0 )
2020	2019	PARTNERSHIP TO END ADDICTION	485 LEXINGTON AVE STE 300	NEW YORK	NY	10017	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	3	9/25/2020	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2019 ( Subtotal = $256,734 )
2019	2019	NATIONAL CENTER ON ADDICTION AND SUBSTANCE ABUSE, THE	633 3RD AVE FL 19	NEW YORK	NY	10017	NEW YORK	USA	Drug Abuse and Addiction Research Programs	001	3	8/22/2019	NON-COMPETING CONTINUATION	$256,734
2019	2018	NATIONAL CENTER ON ADDICTION AND SUBSTANCE ABUSE, THE	633 3RD AVE FL 19	NEW YORK	NY	10017	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	2	10/23/2018	NON-COMPETING CONTINUATION	$0
														Subtotal = $256,734

Issue Date FY: 2018 ( Subtotal = $256,031 )
2018	2018	NATIONAL CENTER ON ADDICTION AND SUBSTANCE ABUSE, THE	633 3RD AVE FL 19	NEW YORK	NY	10017	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	2	9/6/2018	NON-COMPETING CONTINUATION	$256,031
														Subtotal = $256,031

Issue Date FY: 2017 ( Subtotal = $257,322 )
2017	2017	NATIONAL CENTER ON ADDICTION AND SUBSTANCE ABUSE, THE	633 3RD AVE FL 19	NEW YORK	NY	10017	NEW YORK	USA	Drug Abuse and Addiction Research Programs	000	1	9/5/2017	NEW	$257,322
														Subtotal = $257,322

Grand Total All Awards = $760,115

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Testing a System-level Implementation Intervention to Improve the Quality of Family-Based Services for Adolescent Substance Use

Award Number: R34DA044740

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer